Hillrom More Than Doubles Production Of Critical Care Products, Including Ventilators, Hospital Beds And Vitals Monitoring Devices To Support COVID-19 Response

CHICAGO, March 24, 2020 - Hillrom (NYSE: HRC) today announced actions it is taking to support customers and caregivers with critical care products necessary to meet COVID-19 patient needs. 

Hillrom Announces More Than $5.5 Million In Donations To Expand Access To COVID-19 Pandemic Care

CHICAGO, March 19, 2020 - Hillrom (NYSE: HRC) today announced it is donating an additional $3 million in medical devices well-suited for critical and intensive care environments to 25 U.S. hospitals fighting COVID-19. Combined with prior donations in Asia, Europe and other philanthropic activities in our communities, Hillrom donations to assist caregivers and patients in the current pandemic total more than $5.5 million to date.

Hillrom Raises Quarterly Dividend

CHICAGO, Feb. 26, 2020 - Hillrom (NYSE: HRC) announced today that its board of directors declared a 5 percent increase in the company's quarterly dividend rate, from the previous rate of $0.21 per share to $0.22 per share. The fiscal second quarter 2020 quarterly dividend is payable on March 31, 2020, to shareholders of record as of the close of business on March 23, 2020. The indicated annual dividend rate is $0.88 per share.

Hillrom to Present at the Barclays Global Healthcare Conference

CHICAGO, Feb. 25, 2020 - Hillrom (NYSE: HRC), will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2020, in Miami, Florida. Barbara Bodem, Hillrom's chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time.  

Hillrom Improves Hypertension Detection With New Welch Allyn® Spot Vital Signs® 4400 Device

CHICAGO , Feb. 3, 2020 - Global medical technology leader Hillrom today announced the commercial launch of the new Welch Allyn® Spot Vital Signs® 4400, an easy-to-use next-generation vital signs device ideal for ambulatory and emergency department settings.